← Eichor
Study identifier: NCT06258707 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

Condition: Aphakia  ·  Sponsor: Cutting Edge SAS

PhaseNA
Planned participants58
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.

This description comes directly from the study's public registry record.

Talk to the study team

Ilham XHAARD  ·  620 050 651  ·  ilham.xhaard@cutting-edge.fr

Line BETTINELLI  ·  619 530 701  ·  line.bettinelli@cutting-edge.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Clinique Honore CaveMontauban, FranceRecruiting
West OphtaRennes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06258707